Registered entities
Ablative Solutions Inc.
Reg. No. 452908916United States
Innovation
28 patent families (19 granted) — focus: Human necessities; filing pace steady. Cited 18,890 times.
| Year | Filings |
|---|---|
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 14 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 10 |
Investor mix
15 investors on record; lead investors include Charter Capital Partners, BioStar Capital, Gilde Healthcare, BioStar Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 33% |
| Private equity | 7 | 47% |
| Bank & private debt | 2 | 13% |
| Other / undisclosed | 1 | 7% |